https://www.selleckchem.com/products/U0126.html
novel treatment option for patients with KIT-mutant melanoma that are refractory to standard therapy. NCT04546074. Date of Registration September 11, 2020 (https//clinicaltrials.gov/ct2/show/NCT04546074). Date of First Participant Enrollment December 23, 2020. NCT04546074. Date of Registration September 11, 2020 (https//clinicaltrials.gov/ct2/show/NCT04546074). Date of First Participant Enrollment December 23, 2020. Hydrocephalus is a common disease in neurosurgery. The typical symptoms of hydrocephalus include urinary incontinence, gait
Beğen
Yorum Yap
Paylaş
